AU2002348738B2 - The method of treating cancer - Google Patents

The method of treating cancer Download PDF

Info

Publication number
AU2002348738B2
AU2002348738B2 AU2002348738A AU2002348738A AU2002348738B2 AU 2002348738 B2 AU2002348738 B2 AU 2002348738B2 AU 2002348738 A AU2002348738 A AU 2002348738A AU 2002348738 A AU2002348738 A AU 2002348738A AU 2002348738 B2 AU2002348738 B2 AU 2002348738B2
Authority
AU
Australia
Prior art keywords
mycobacterium
cancer
pharmaceutical composition
adjuvant
management
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002348738A
Other languages
English (en)
Other versions
AU2002348738A1 (en
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cadila Pharmaceuticals Ltd
Original Assignee
Cadila Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd filed Critical Cadila Pharmaceuticals Ltd
Publication of AU2002348738A1 publication Critical patent/AU2002348738A1/en
Application granted granted Critical
Publication of AU2002348738B2 publication Critical patent/AU2002348738B2/en
Assigned to CADILA PHARMACEUTICALS LIMITED reassignment CADILA PHARMACEUTICALS LIMITED Request for Assignment Assignors: Khumar, Bakulesh Mafatlal
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002348738A 2001-12-10 2002-12-10 The method of treating cancer Ceased AU2002348738B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1167/MUM/2001 2001-12-10
IN1167MU2001 2001-12-10
PCT/IB2002/005516 WO2003049667A2 (en) 2001-12-10 2002-12-10 The method of treating cancer

Publications (2)

Publication Number Publication Date
AU2002348738A1 AU2002348738A1 (en) 2003-06-23
AU2002348738B2 true AU2002348738B2 (en) 2007-11-08

Family

ID=11097334

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002348738A Ceased AU2002348738B2 (en) 2001-12-10 2002-12-10 The method of treating cancer

Country Status (9)

Country Link
US (1) US7972609B2 (enExample)
JP (1) JP4527979B2 (enExample)
AP (1) AP1896A (enExample)
AU (1) AU2002348738B2 (enExample)
CA (1) CA2469266C (enExample)
GB (1) GB2389532C (enExample)
NZ (1) NZ533417A (enExample)
UA (1) UA79952C2 (enExample)
WO (1) WO2003049667A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2632353C (en) 2005-04-25 2018-02-20 Bakulesh Mafatlal Khamar Vaccine adjuvants comprising mycobaterium
AU2007323134B2 (en) * 2006-11-23 2013-05-02 Cadila Pharmaceuticals Limited Poly-TLR antagonist
CA2681420A1 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
AU2008269427A1 (en) * 2007-06-28 2008-12-31 Cadila Pharmaceuticals Ltd. Mitogen activated protein kinase modulator
WO2011083493A1 (en) * 2010-01-08 2011-07-14 National Institute Of Immunology Human chorionic gonadotropin (hcg) based vaccine for prevention and treatment of cancer
CN102753975B (zh) * 2010-02-19 2015-05-20 卡帝拉药物有限公司 基本上保留免疫原性的被杀死细胞的药物组合物
WO2012049654A1 (en) * 2010-10-13 2012-04-19 Bioniche Life Sciences, Inc. Bacterial ribonucleic acid cell wall compositions and methods of making and using them
PL2663318T3 (pl) * 2011-01-11 2015-08-31 Cadila Pharmaceuticals Ltd Kompozycja farmaceutyczna do leczenia raka
TR201101874A2 (tr) * 2011-02-25 2011-08-22 Leyla A�An Nac�Ye Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.
CA2828401C (en) * 2011-02-28 2023-01-10 Cadila Pharmaceuticals Limited Therapeutic cancer vaccine
ES2647768T3 (es) * 2011-07-05 2017-12-26 Cadila Pharmaceuticals Limited Antígeno de cáncer
US20200368293A1 (en) * 2018-01-18 2020-11-26 Vedanta Biosciences, Inc. Compositions and methods for the treatment of cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504005A (en) * 1987-03-02 1996-04-02 Albert Einstein College Of Medicine Of Yeshiva University Recombinant mycobacterial vaccine
US6126945A (en) 1989-10-03 2000-10-03 Pharmacia Ab Tumor killing effects of enterotoxins, superantigens, and related compounds
IL105503A (en) 1992-04-28 1999-05-09 Astra Ab Carbon peptide couplets capable of eliciting an immune response of T cells
GB9223816D0 (en) * 1992-11-13 1993-01-06 Medical Res Council Heat shock proteins and the treatment of tumours
US5767156A (en) 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
US6090385A (en) 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
US6056964A (en) 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
US5869645A (en) 1997-10-15 1999-02-09 Board Of Trustees Of The University Of Illinois Method for isolating high molecular weight antineoplastic glycans using urea
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
BR0303367A (pt) * 2002-03-08 2004-07-20 Bakulesh Mafatlal Khamar Células de mycobacterium w, veìculo farmaceuticamente aceitável, preservativo, ruptura de mycobacterium w, extração de solvente, enzimas usadas para a extração enzimática de células de mycobacterium w, adjuvante, composição farmacêutica, tensoativo, e, concentração de tensoativo do processo de fabricar uma composição farmacêutica para a administração de tuberculose

Also Published As

Publication number Publication date
AU2002348738A1 (en) 2003-06-23
CA2469266C (en) 2014-02-11
UA79952C2 (en) 2007-08-10
JP4527979B2 (ja) 2010-08-18
CA2469266A1 (en) 2003-06-19
AP1896A (en) 2008-10-08
WO2003049667A2 (en) 2003-06-19
GB2389532A (en) 2003-12-17
US20070259005A1 (en) 2007-11-08
US7972609B2 (en) 2011-07-05
GB0322773D0 (en) 2003-10-29
NZ533417A (en) 2008-04-30
AP2004003070A0 (en) 2004-06-30
GB2389532B (en) 2004-10-27
JP2005528332A (ja) 2005-09-22
WO2003049667A3 (en) 2003-10-09
GB2389532C (en) 2005-09-08

Similar Documents

Publication Publication Date Title
CA1333152C (en) Vaccine containing tumor antigens and adjuvants
JP2022538765A5 (enExample)
US7972609B2 (en) Method of treating cancer
WO2003049751A1 (en) The process of manufacturing a pharmaceutical composition useful for management of cancer
JP2014512388A (ja) 免疫反応を増進するための組成物および方法
Lee et al. T cell augments the antitumor activity of tumor-targeting Salmonella
JPH08508976A (ja) 改善化免疫療法用組成物
US9056073B2 (en) Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
Divyashree et al. Bugs as drugs: Neglected but a promising future therapeutic strategy in cancer
WO2017185016A1 (en) Skin disorder therapeutics and methods of use
Steenken Jr et al. Vaccinating properties of avirulent dissociates of five different strains of tubercle bacilli
ES2231037B1 (es) Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos.
WO2023056962A1 (zh) 戈氏梭菌芽孢联合帕博利珠单抗的应用
WO2010031883A1 (es) Agente inmunoterapéutico apropiado para la profilaxis primaria de la tuberculosis
CN101518549A (zh) 分枝杆菌提取物的研究和应用
Julián et al. Bacteria-derived alternatives to live Mycobacterium bovis Bacillus Calmette-Guerin for nonmuscle invasive bladder cancer treatment
WO2003075824A2 (en) Process of manufacturing pharmaceutical composition useful for management of tuberculosis
Noguera-Ortega et al. Mycobacteria-derived agents for the treatment of urological and renal cancers
CA2136870C (fr) Complexe immunomodulateur anti-sida
WO2003075825A2 (en) The method of treating tuberculosis
CA2474794A1 (en) Method of providing prophylaxis for tuberculosis in hiv positive individuals
US6806253B2 (en) Immunodulatory complex and use thereof in helicobacter diseases
WO2003063896A1 (en) Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
AU2003202725A1 (en) Method of providing prophylaxis for tuberculosis in HIV positive individuals
JP2005519942A (ja) 喘息（閉塞性肺疾患）の治療のためのマイコバクテリウムｗを含有する医薬組成物の製造方法

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: CADILA PHARMACEUTICALS LIMITED

Free format text: FORMER APPLICANT(S): KHUMAR, BAKULESH MAFATLAL

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired